IQVIA Holdings Inc
NYSE:IQV
Intrinsic Value
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. [ Read More ]
The intrinsic value of one
IQV
stock under the Base Case scenario is
287.97
USD.
Compared to the current market price of 196.75 USD,
IQVIA Holdings Inc
is
Undervalued by 32%.
Whether you're assessing long-term stability or short-term opportunities, Historical Valuation serves as a vital tool to enhance your investment approach, enabling you to make more informed investment decisions.
Sign up
to access IQVIA Holdings Inc's intrinsic value history.
No restrictions, no limits.
All stocks, all tools.
Look for stocks that have been historically overvalued but are now trading below their intrinsic value.
Avoid stocks that are always undervalued and never reach their intrinsic value.
Find stocks that have historically corrected quickly from being undervalued to reaching their intrinsic value.
There are two methods to calculate the Intrinsic Value of a stock: DCF Valuation and Relative Valuation. We take the average of these two methods to estimate the intrinsic value as accurately as possible. You can see the Intrinsic Value of a stock at the top of this page.
DCF Value
Discounted Cash Flow
Fundamental Analysis
Balance Sheet Decomposition
IQVIA Holdings Inc
| Current Assets | 5.3B |
| Cash & Short-Term Investments | 1.5B |
| Receivables | 3.2B |
| Other Current Assets | 653m |
| Non-Current Assets | 20.7B |
| Long-Term Investments | 208m |
| PP&E | 829m |
| Intangibles | 19.1B |
| Other Non-Current Assets | 550m |
| Current Liabilities | 6.5B |
| Accounts Payable | 3B |
| Other Current Liabilities | 3.5B |
| Non-Current Liabilities | 13.7B |
| Long-Term Debt | 12.4B |
| Other Non-Current Liabilities | 1.3B |
IQV Profitability Score
Profitability Due Diligence
IQVIA Holdings Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
IQVIA Holdings Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
IQV Solvency Score
Solvency Due Diligence
IQVIA Holdings Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Score
IQVIA Holdings Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IQV Price Targets Summary
IQVIA Holdings Inc
According to Wall Street analysts, the average 1-year price target for
IQV
is 255.86 USD
with a low forecast of 217.15 USD and a high forecast of 295.05 USD.
Ownership
IQV Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
IQV Price
IQVIA Holdings Inc
| Average Annual Return | 23.14% |
| Standard Deviation of Annual Returns | 29.13% |
| Max Drawdown | -49% |
| Market Capitalization | 36B USD |
| Shares Outstanding | 185 549 000 |
| Percentage of Shares Shorted | 1.96% |
Company Profile
IQVIA Holdings Inc
Country
Industry
Market Cap
Dividend Yield
Description
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 79,000 full-time employees. The company went IPO on 2013-05-09. The Company’s segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions, which primarily serves biopharmaceutical clients, is engaged in research and development and provides clinical research and clinical trial services. Contract Sales & Medical Solutions provides contract sales to both biopharmaceutical clients and the broader healthcare market.
Contact
IPO
Employees
Officers
The intrinsic value of one
IQV
stock under the Base Case scenario is
287.97
USD.
Compared to the current market price of 196.75 USD,
IQVIA Holdings Inc
is
Undervalued by 32%.
Sensibly Priced Quality
Significantly Undervalued
Magic Formula
High Growth
